wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q54349937-058E74FF-85DC-4EAA-BD41-635B354BAB25
Q54349937-058E74FF-85DC-4EAA-BD41-635B354BAB25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54349937-058E74FF-85DC-4EAA-BD41-635B354BAB25
Managing postmenopausal women with hormone receptor-positive advanced breast cancer who progress on endocrine therapies with inhibitors of the PI3K pathway.
P2860
Q54349937-058E74FF-85DC-4EAA-BD41-635B354BAB25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54349937-058E74FF-85DC-4EAA-BD41-635B354BAB25
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0207bca23e7e5013b6bea46ed3d56e463a20d10e
P2860
A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure.